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Abstract
Background: Guided by the evidence that delaying coronary revascularization may lead to symptom worsening and
poorer clinical outcomes, expansion in cardiac surgery capacity has been recommended in Canada. Provincial
governments started providing one-time and recurring increases in budgets for additional open heart surgeries to
reduce waiting times. We sought to determine whether the year of decision to proceed with non-emergency
coronary bypass surgery had an eﬀect on time to surgery.
Methods: Using records from a population-based registry, we studied times between decision to operate and the
procedure itself. We estimated changes in the length of time that patients had to wait for non-emergency operation
over 14 calendar periods that included several years when supplementary funding was available. We studied waiting
times separately for patients who access surgery through a wait list and through direct admission.
Results: During two periods when supplementary funding was available, 1998–1999 and 2004–2005, the weekly rate
of undergoing surgery from a wait list was, respectively, 50% and 90% higher than in 1996–1997, the period with the
longest waiting times. We also observed a reduction in the diﬀerence between 90th and 50th percentiles of the
waiting-time distributions. Forty percent of patients in the 1998, 1999, 2004 and 2005 cohorts (years when
supplementary funding was provided) underwent surgery within 16 to 20 weeks following the median waiting time,
while it took between 27 and 37 weeks for the cohorts registered in the years when supplementary funding was not
available. Times between decision and surgery were shorter for direct admissions than for wait-listed patients. Among
patients who were directly admitted to hospital, time between decision and surgery was longest in 1992–1993 and
then has been steadily decreasing through the late nineties. The rate of surgery among these patients was the highest
in 1998–1999, and has not changed afterwards, even for years when supplementary funding was provided.
Conclusions: Waiting times for non-emergency coronary bypass surgery shortened after supplementary funding
was granted to increase volume of cardiac surgical care in a health system with publicly-funded universal coverage for
the procedure. The eﬀect of the supplementary funding was not uniform for patients that access the services through
wait lists and through direct admission.
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Background
In Canada, provincial health insurance plans provide uni-
versal, single-payer coverage for surgical coronary revas-
cularization, a procedure indicated for the treatment of
coronary artery disease [1]. Responsible for the delivery of
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care, regional Health Authorities budget a ﬁxed number of
open heart surgeries on an annual basis using population-
based rates of the disease [2]. As argued elsewhere, those
whomake allocation decisions have no tools to predict the
volume of demand at each hospital and at each point dur-
ing the calendar period [3].When demand exceeds funded
capacity, cardiac centers across Canada use wait lists to
manage access to the procedure. As a result, operations for
patients with less severe coronary artery disease may be
delayed when a surgical service experiences an extended
demand for more urgent procedures [4-10]. Guided by the
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evidence that delaying the operation may lead to symp-
tom worsening and poorer clinical outcomes, expansion
in cardiac surgery capacity has been recommended in
Canada. Federal and provincial governments started pro-
viding one-time and recurring increases in budgets for
additional open heart surgeries to reduce the number
of patients waiting for coronary artery bypass grafting
(CABG) and their waiting times.
In a previous study of access to non-emergency CABG
in British Columbia, Canada, between 1991 and 2000, we
found that waiting times for the procedure shortened after
1998 when annual supplementary funding was granted to
tertiary care hospitals that had been providing cardiac sur-
gical care to adult residents of the province [8]. Between
1995–1996 and 1999–2000, there was a 12% increase
in the total number of CABG operations and a decline
in median waiting time from 15 to 10 weeks, although
the change in waiting times was diﬀerent across urgency
groups. In addition, between 1995–1996 and 1999–2000
there was a decrease from 54% to 41% in the proportion
of patients undergoing the procedure through wait lists.
Considering that cardiac surgeons in British Columbia
have discretion for direct admission of their patients on
the basis of the estimated urgency of treatment, place of
residence and other factors, this might indicate that sup-
plementary funding had been used to provide more treat-
ments without delay. One plausible explanation for these
results was that the hospitals had capacity to increase the
number of operations and thereby reduce wait times [10].
However, a limitation of the previous study was the short
period for analysis of the eﬀects of supplementary fund-
ing (two years). In addition, data were not available for
the total amount of time between cardiac catheterization
and surgical revascularization. As such, in the previous
study we did not estimate the eﬀect of the supplementary
funding on waiting times in full.
Since our previous analysis, another $2 million of addi-
tional funding from the provincial Ministry of Health was
directed in each of 2003 and 2004 toward open heart
surgery to increase the volume. However, the eﬀect of this
increase in funding on wait-list sizes and waiting times
for CABG remains unknown. The longer time frame after
the original increase in annual budgets for CABG since
1998 and the additional funding in 2003 and 2004 makes
it feasible to generate more precise assessment of this
supply-side initiative to improve access to care. The eﬀect
of the additional funding has not been contrasted for two
diﬀerent pathways of accessing surgical coronary revascu-
larization for non-emergency patients as well. Access to
non-emergency CABG could be provided either through
a wait list or through direct admission to hospital, and it
remains unclear whether the eﬀect of the supplementary
funding was uniform for the wait-listed and directly-
admitted patients. However this information is important
for deciding on policy to reduce wait lists by adding extra
funding.
To evaluate the eﬀect of providing the additional fund-
ing to tertiary care hospitals on access to non-emergency
surgical revascularization within a single publicly funded
health system, we estimated temporal changes in the
length of time between decision to proceed with surgery
and performed CABG. We used all relevant records from
the provincial population-based registry of patients with
angiographically-proven coronary artery disease iden-
tiﬁed as needing bypass surgery on a non-emergency
basis. To adjust for changes in time between cardiac
catheterization and decision to operate, we used the
most recent catheterization date from hospital discharge
reports assuming that the results of this procedure (coro-
nary angiography or intervention) were most likely linked
to the decision to operate. Primary comparisons have
been done across synthetic cohorts of patients deﬁned
by the calendar period of the decision to proceed with
surgery. The temporal changes in treatment delays have
been estimated separately for patients who access surgery
by registration on a wait list and among patients who
access surgery by direct admission.
Methods
Data sources
Data were obtained from the British Columbia Cardiac
Registries (BCCR) to identify the study participants and
their characteristics. This population-based patient reg-
istry contains demographic, clinical and treatment data,
along with the dates of booking request for operating
room time and procedures for all adult patients under-
going CABG in any of the four cardiac centers in the
province [8]. To identify cardiac catheterization dates,
hospital admission and discharge dates, and coexisting
medical conditions, we used each patient’s provincial
health number to deterministically link BCCR records
to the Canadian Institute for Health Information (CIHI)
Discharge Abstract Database (DAD) [11].
Patients
Using records from the registry, we studied two groups
of patients: (1) those who were registered on a wait list
for ﬁrst-time isolated CABG surgery; and (2) those who
underwent the procedure by direct admission to hospital
on a non-emergency basis. Patients who accessed surgery
through a wait list were registered by the surgeon’s oﬃce
on the wait list after an outpatient consultation with a car-
diac surgeon. In contrast, patients who accessed surgery
through direct admission were admitted to a hospital’s
cardiac ward directly from the catheterization labora-
tory or after an outpatient consultation with a cardiac
surgeon if the patient had disabling symptoms or high-
risk anatomy of the coronary lesion(s). Patients in both
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groups were classiﬁed as urgent, semiurgent, or nonurgent
based on the patient’s need for treatment, as deﬁned
elsewhere [8].
The inception cohort of wait-listed patients had a
total of 14,049 records of registration for CABG from
January 1, 1991 through December 31, 2005. We excluded
567 records of patients for various reasons: procedure at
registration was not isolated CABG (312), procedure at
registration or at surgery was not ﬁrst-time CABG (62),
emergency cases at the time of registration (34), missing
operating room reports (4), removed on the registration
date (101), registration was on a weekend and admission
was the day after (14), or the patient hadmultiple episodes
(40). We also excluded 1,452 records of patients who were
registered in 1991 (797) or did not have a catheterization
date (655).
The inception cohort of direct admissions had a total
of 16,014 records of CABG surgery from January 1, 1991
throughDecember 31, 2005.We excluded 1,282 records of
patients for various reasons: procedure at surgery was not
isolated CABG (211), procedure at surgery was not ﬁrst-
time CABG (54), emergency case at the time of surgery
(861), or the patient had multiple episodes (156). We also
excluded 1,914 records of patients who had surgery in
1991 (1,031), did not have a catheterization date (838),
did not have an admission date (38), or had a decision to
operate in 1991 (7).
The ﬁnal study cohort had a total of 12,030 wait-listed
patients who had a decision to undergo ﬁrst-time isolated
CABG surgery and 12,818 direct admissions who under-
went ﬁrst-time isolated CABG surgery from January 1,
1992 through December 31, 2005. Among the wait-listed
patients 10,339 (85.9%) underwent surgery within 1 year
of registration and the remaining were removed from the
list without surgery: 104 (0.9%) died, 257 (2.1%) continued
to receive medical treatment, 231 (1.9%) declined surgery,
86 (0.7%) were transferred to another surgeon or hospi-
tal, 321 (2.7%) were removed for other reasons, and 692
(5.8%) remained on the list after 52 weeks or at the end of
the study period.
Primary study variable
The primary study variable was calendar period of
decision to operate classiﬁed into 7 two-year periods:
1992–93, 1994–95, 1996–97, 1998–99, 2000–01, 2002–
03, 2004–05. Calendar periods are often used as a proxy
for changes in the availability of hospital resources, such
as, surgical staﬃng, operating room time, special equip-
ment, and beds, in studies that attempted to explain vari-
ations in the patient’s waiting time for surgery [12,13].
Because the budget for open heart surgeries is deter-
mined annually, calendar period provides an appropriate
indicator for changes in the funded procedures.
Outcome
The outcome was time between decision to operate and
surgical revascularization. This time was measured in cal-
endar weeks for wait-listed patients and in days for direct
admissions. We used the date of the registration on a
wait list as a proxy for the decision to operate for wait-
listed patients and the date of catheterization or the date
of admission to hospital, whichever was most recent, as
a proxy for the date of decision to operate for directly-
admitted patients. This latter rule reﬂects variation in care
paths of the patients: following angiography the patient
may be admitted for in-hospital consultation with a car-
diac surgeon, or patients who live far away are admitted
for angiography, stay in hospital to undergo tests, and
are booked for surgery or discharged with planned re-
admission.
Potential confounders
The existing literature suggests that elderly patients are
more likely to undergo revascularization as an urgent pro-
cedure [14], that smaller diameter of the coronary vessels
may account for the higher risk of adverse cardiovascu-
lar events among women [15], that co-existing conditions
may delay open heart surgery [16], that post-operative
survival depends on institutional constraints and indi-
vidual care providers [17], and that changes in practice
may reduce the waiting time until surgery [8]. To iden-
tify comorbidities at the time of decision to operate, we
used diagnoses reported in the DADwithin one year prior
to decision. The reference category was deﬁned as no
coexisting conditions. The ﬁrst comparison category was
deﬁned as patients with any of the following conditions
at presentation: congestive heart failure, diabetes mel-
litus, chronic obstructive pulmonary disease, cancer, or
rheumatoid arthritis [4]. The second comparison category
was deﬁned as patients presenting with other coexisting
chronic conditions, as deﬁned elsewhere [18].
In addition, we used time between cardiac catheteri-
zation and decision to operate as a covariate that might
reﬂect changes in practice over time. The time between
catheterization and decision measured in calendar weeks.
The catheterization dates were obtained from the DAD
and deﬁned as the most recent diagnostic (Canadian Clas-
siﬁcation of Procedure (CCP) codes 4892–4898, 4996,
4997) or therapeutic (CCP codes 4802, 4803, 4809)
catheterization performed within one year preceding and
including the date of booking for wait-listed patients
or within one year preceding and including the date of
surgery for direct admissions. We used the date of most
recent catheterization procedures (diagnostic or thera-
peutic) because the results of this procedure are most
likely linked to decision to operate [19]. We used calendar
weeks as the unit of time because scheduling of surgical
procedures is done on a weekly basis [13].
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Statistical analysis
We used chi-square testing to compare the distributions
of patient characteristics across calendar period of deci-
sion for wait-listed patients and direct admissions. We
estimated percentiles and conditional median times to
surgery to characterize the variation in times to surgi-
cal revascularization, by calendar period for each type of
access. Percentiles of time to surgery were estimated using
the product-limit method [13,20]. The conditional median
waiting time at a given moment after decision is deﬁned
as the period during which one half of the patients who
wait for surgery are expected to have it [13]. For wait-listed
patients, average weekly surgery rates were calculated as
the number of procedures divided by the sum of observed
times from decision to surgery or removal from the wait
list. For direct admissions, the average daily surgery rates
were calculated as the number of procedures divided by
the sum of observed times from decision to surgery.
Discrete-time survival regression methods were used to
model the relation between the time to surgical revascu-
larization and calendar period of decision for each type of
access [13,21]. We restricted the regression analysis to the
ﬁrst 52 weeks after decision for wait-listed patients and to
the ﬁrst 7 days after decision for direct admissions. The
calendar period was entered into the regression model as
a set of 6 binary indicators. The 1996–1997 group (i.e., the
reference group) took a value of 0 for all indicator vari-
ables. The exponential of the regression coeﬃcient for an
indicator variable for a period gave the odds of surgery in
that period relative to the odds of surgery in 1996–1997. In
a multivariable model, we adjusted for sex, age at decision,
urgency at decision, institution at decision, comorbidi-
ties at decision, coronary anatomy at decision, and time
between catheterization and decision.
To explore the eﬀect of the supplementary funding on
direct admissions and wait-listed patients, we classiﬁed
all patients using the algorithm developed by Northern
New England Cardiovascular Disease Study Group [22].
For each patient, we calculated the prognostic risk of
in-hospital death that summarized the eﬀect of clinical
and patient characteristics. We then compared the dis-
tribution of these risks between direct admissions and
wait-listed patients for each calendar period of surgery
using chi-square testing.
The Behavioural Research Ethics Board of the Univer-
sity of British Columbia approved the study protocol,
Certiﬁcate of Approval H06-80651.
Results
Patients characteristics
Overall 24,848 patients had a decision for ﬁrst-time, iso-
lated CABG between 1992 and 2005: 12,030 (48%) were
registered on a wait list and 12,818 (52%) were directly
admitted to hospital.
For wait-listed patients, the distribution of patient char-
acteristics varied across periods (Table 1). The majority of
the wait-listed patients who had a decision for CABGwere
men (83%). Later periods tended to have older patients
(p < 0.001), fewer urgent cases at decision (p < 0.001),
more patients with major comorbidities at the time of
decision (p < 0.001), and more limited coronary anatomy
aﬀected (p < 0.001). The distribution of cases by insti-
tution at decision seemed to increase over periods for
hospital 1, but decreased for hospital 2 (p < 0.001). The
majority of wait-listed patients had a decision to oper-
ate within a week of catheterization. This majority ranged
from about 42% in 1992–1993 and increased to 65% in
2002–2003 (p < 0.001).
For direct admissions, the trends in changes in the
distributions of patient characteristics over periods were
similar to wait-listed patients (Table 2). Later periods
tended to have older patients (p < 0.001), fewer urgent
cases at decision (p < 0.001), and more patients with
major comorbidities at the time of decision (p < 0.001).
In contrast to wait-listed patients, later periods tended to
have more direct admissions who had less limited coro-
nary anatomy aﬀected (p < 0.001) and more decisions
to operate within a week of catheterization (p < 0.001).
About two-thirds of direct admissions had a decision to
operate within a week of catheterization across all calen-
dar periods.
When compared over calendar periods, wait-listed
patients were more prevalent in the low risk group
and directly-admitted patients were more prevalent in
high risk group (see Table 3). The percentage of low
risk patients accessing surgery through direct admis-
sion declined considerably in years when supplementary
funding was provided.
Access to surgery through wait-list registration
Figure 1 shows the cumulative distribution functions of
waiting time for each calendar period, which could be
used to derive the number of weeks required for a spec-
iﬁed proportion of patients to undergo the operation.
The diﬀerences in the proportion of patients undergo-
ing CABG within a certain time of decision were sig-
niﬁcant across periods (Log-rank statistic = 545.6, df=6,
p < 0.001), with longer waiting times when the deci-
sion was made in 1996–1997 and 2002–2003. The waiting
times for these years were such that half of the wait-listed
patients underwent surgery within 16 to 17 weeks, and
90% underwent surgery within 46 to 51 weeks. In contrast,
during the other years about half of patients underwent
surgery within 8 to 14 weeks of decision. Comparing the
1998, 1999, 2004 and 2005 cohorts (the periods when sup-
plement funding was provided) with the rest, we observed




















Table 1 Characteristics of 12,030 wait-list registered patients, who had decision for coronary artery bypass grafting in British Columbia 1992–2005, by calendar
period of decision
All periods 1992–1993 1994–1995 1996–1997 1998–1999 2000–2001 2002–2003 2004–2005
Characteristic (n = 12030) (n = 1726) (n = 1793) (n = 1862) (n = 1610) (n = 1791) (n = 1889) (n = 1359)
Age group at decision (years)
<50 761 (6.3) 140 (8.1) 147 (8.2) 118 (6.3) 99 (6.1) 113 (6.3) 85 (4.5) 59 (4.3)
50–59 2559 (21.3) 362 (21.0) 390 (21.8) 367 (19.7) 337 (20.9) 419 (23.4) 426 (22.6) 258 (19.0)
60–69 4468 (37.1) 703 (40.7) 655 (36.5) 717 (38.5) 551 (34.2) 619 (34.6) 717 (38.0) 506 (37.2)
70–79 3786 (31.5) 500 (29.0) 542 (30.2) 602 (32.3) 567 (35.2) 573 (32.0) 551 (29.2) 451 (33.2)
≥80 456 (3.8) 21 (1.2) 59 (3.3) 58 (3.1) 56 (3.5) 67 (3.7) 110 (5.8) 85 (6.3)
Sex
Men 9981 (83.0) 1425 (82.6) 1487 (82.9) 1500 (80.6) 1334 (82.9) 1502 (83.9) 1595 (84.4) 1138 (83.7)
Women 2049 (17.0) 301 (17.4) 306 (17.1) 362 (19.4) 276 (17.1) 289 (16.1) 294 (15.6) 221 (16.3)
Urgency at decision∗
Urgent 739 (6.1) 113 (6.5) 162 (9.0) 177 (9.5) 66 (4.1) 72 (4.0) 87 (4.6) 62 (4.6)
Semiurgent 8769 (72.9) 1331 (77.1) 1240 (69.2) 1295 (69.5) 1107 (68.8) 1315 (73.4) 1401 (74.2) 1080 (79.5)
Nonurgent 2304 (19.2) 269 (15.6) 375 (20.9) 369 (19.8) 432 (26.8) 390 (21.8) 354 (18.7) 115 (8.5)
Institution at decision
1 2668 (22.2) 328 (19.0) 356 (19.9) 378 (20.3) 361 (22.4) 449 (25.1) 533 (28.2) 263 (19.4)
2 3575 (29.7) 724 (41.9) 589 (32.8) 467 (25.1) 555 (34.5) 475 (26.5) 409 (21.7) 356 (26.2)
3 2914 (24.2) 438 (25.4) 429 (23.9) 492 (26.4) 265 (16.5) 401 (22.4) 472 (25.0) 417 (30.7)
4 2873 (23.9) 236 (13.7) 419 (23.4) 525 (28.2) 429 (26.6) 466 (26.0) 475 (25.1) 323 (23.8)
Comorbidities at decision
Major conditions† 2901 (24.1) 373 (21.6) 386 (21.5) 418 (22.4) 368 (22.9) 452 (25.2) 518 (27.4) 386 (28.4)
Other conditions‡ 2856 (23.7) 520 (30.1) 496 (27.7) 526 (28.2) 384 (23.9) 379 (21.2) 354 (18.7) 197 (14.5)
None 6273 (52.1) 833 (48.3) 911 (50.8) 918 (49.3) 858 (53.3) 960 (53.6) 1017 (53.8) 776 (57.1)
Coronary anatomy aﬀected at decision
Left main 1780 (14.8) 251 (14.5) 287 (16.0) 299 (16.1) 256 (15.9) 265 (14.8) 284 (15.0) 138 (10.2)
Multivessel§ 8715 (72.4) 1361 (78.9) 1407 (78.5) 1418 (76.2) 1202 (74.7) 1320 (73.7) 1274 (67.4) 733 (53.9)




















Table 1 Characteristics of 12,030 wait-list registered patients, who had decision for coronary artery bypass grafting in British Columbia 1992–2005, by calendar
period of decision (Continued)
Time between catheterization and decision for surgical revascularization (weeks)
0–1 6651 (55.3) 726 (42.1) 932 (52.0) 1005 (54.0) 912 (56.6) 1093 (61.0) 1236 (65.4) 747 (55.0)
2–3 2066 (17.2) 422 (24.4) 377 (21.0) 350 (18.8) 269 (16.7) 245 (13.7) 215 (11.4) 188 (13.8)
4–5 1041 (8.7) 209 (12.1) 174 (9.7) 157 (8.4) 150 (9.3) 139 (7.8) 102 (5.4) 110 (8.1)
6–7 642 (5.3) 122 (7.1) 92 (5.1) 123 (6.6) 74 (4.6) 84 (4.7) 66 (3.5) 81 (6.0)
≥8 1630 (13.5) 247 (14.3) 218 (12.2) 227 (12.2) 205 (12.7) 230 (12.8) 270 (14.3) 233 (17.1)
*218 patients had unknown values for urgency at decision.
†Congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, rheumatoid arthritis, or cancer.
‡Peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver disease.
§Two or three-vessel disease with stenosis of the proximal left anterior descending (PLAD) artery.




















Table 2 Characteristics of 12,818 direct admissions, who had decision for coronary artery bypass grafting in British Columbia 1992–2005, by calendar period of
decision
All periods 1992–1993 1994–1995 1996–1997 1998–1999 2000–2001 2002–2003 2004–2005
Characteristic (n = 12818) (n = 1204) (n = 1474) (n = 1621) (n = 2089) (n = 2121) (n = 1940) (n = 2369)
Age group at decision (years)
<50 920 (7.2) 111 (9.2) 97 (6.6) 129 (8.0) 142 (6.8) 157 (7.4) 139 (7.2) 145 (6.1)
50–59 2604 (20.3) 228 (18.9) 275 (18.7) 313 (19.3) 435 (20.8) 432 (20.4) 414 (21.3) 507 (21.4)
60–69 4354 (34.0) 442 (36.7) 569 (38.6) 571 (35.2) 715 (34.2) 676 (31.9) 615 (31.7) 766 (32.3)
70–79 4341 (33.9) 389 (32.3) 481 (32.6) 550 (33.9) 726 (34.8) 747 (35.2) 663 (34.2) 785 (33.1)
≥80 599 (4.7) 34 (2.8) 52 (3.5) 58 (3.6) 71 (3.4) 109 (5.1) 109 (5.6) 166 (7.0)
Sex*
Men 10067 (78.5) 914 (75.9) 1104 (74.9) 1247 (76.9) 1659 (79.4) 1687 (79.5) 1525 (78.6) 1931 (81.5)
Women 2750 (21.5) 290 (24.1) 370 (25.1) 374 (23.1) 430 (20.6) 434 (20.5) 415 (21.4) 437 (18.4)
Urgency at decision
Urgent 5944 (46.4) 727 (60.4) 944 (64.0) 900 (55.5) 1046 (50.1) 887 (41.8) 698 (36.0) 742 (31.3)
Semiurgent 6445 (50.3) 453 (37.6) 485 (32.9) 654 (40.3) 906 (43.4) 1148 (54.1) 1211 (62.4) 1588 (67.0)
Nonurgent 429 (3.3) 24 (2.0) 45 (3.1) 67 (4.1) 137 (6.6) 86 (4.1) 31 (1.6) 39 (1.6)
Institution at decision
1 2437 (19.0) 89 (7.4) 206 (14.0) 295 (18.2) 381 (18.2) 473 (22.3) 427 (22.0) 566 (23.9)
2 2962 (23.1) 342 (28.4) 369 (25.0) 333 (20.5) 466 (22.3) 426 (20.1) 457 (23.6) 569 (24.0)
3 4964 (38.7) 417 (34.6) 623 (42.3) 838 (51.7) 870 (41.6) 799 (37.7) 683 (35.2) 734 (31.0)
4 2455 (19.2) 356 (29.6) 276 (18.7) 155 (9.6) 372 (17.8) 423 (19.9) 373 (19.2) 500 (21.1)
Comorbidities at decision
Major conditions† 5458 (42.6) 413 (34.3) 552 (37.4) 626 (38.6) 885 (42.4) 949 (44.7) 914 (47.1) 1119 (47.2)
Other conditions‡ 6248 (48.7) 708 (58.8) 809 (54.9) 885 (54.6) 1033 (49.4) 1027 (48.4) 857 (44.2) 929 (39.2)
None 1112 (8.7) 83 (6.9) 113 (7.7) 110 (6.8) 171 (8.2) 145 (6.8) 169 (8.7) 321 (13.6)
Coronary anatomy aﬀected at decision
Left main 3184 (24.8) 282 (23.4) 358 (24.3) 377 (23.3) 466 (22.3) 539 (25.4) 534 (27.5) 628 (26.5)
Multivessel§ 8855 (69.1) 814 (67.6) 1019 (69.1) 1136 (70.1) 1501 (71.9) 1470 (69.3) 1307 (67.4) 1608 (67.9)




















Table 2 Characteristics of 12,818 direct admissions, who had decision for coronary artery bypass grafting in British Columbia 1992–2005, by calendar period of
decision (Continued)
Time between catheterization and decision for surgical revascularization (weeks)
0–1 8576 (66.9) 885 (73.5) 1021 (69.3) 991 (61.1) 1381 (66.1) 1465 (69.1) 1246 (64.2) 1587 (67.0)
2–3 2232 (17.4) 164 (13.6) 215 (14.6) 326 (20.1) 334 (16.0) 372 (17.5) 406 (20.9) 415 (17.5)
4–5 592 (4.6) 46 (3.8) 54 (3.7) 81 (5.0) 87 (4.2) 85 (4.0) 113 (5.8) 126 (5.3)
6–7 364 (2.8) 25 (2.1) 38 (2.6) 45 (2.8) 76 (3.6) 46 (2.2) 58 (3.0) 76 (3.2)
≥8 1054 (8.2) 84 (7.0) 146 (9.9) 178 (11.0) 211 (10.1) 153 (7.2) 117 (6.0) 165 (7.0)
*1 direct admission with decision date in 2004–2005 had unknown sex.
†Congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, rheumatoid arthritis, or cancer.
‡Peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver disease.
§Two or three-vessel disease with stenosis of the proximal left anterior descending (PLAD) artery.
‖Two-vessel disease with no stenosis of the PLAD artery or one-vessel disease with stenosis of the PLAD artery.
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Table 3 Prognostic risk of in-hospital death, by calendar period of surgery and type of access
Calendar period of surgery Risk∗, %
Access type <1.0 1.0–3.0 >3.0 p value†
1992–1993 <0.001
Wait-listed 808 (58.4) 555 (40.1) 20 (1.4)
Direct admission 559 (46.2) 581 (48.0) 70 (5.8)
1994–1995 <0.001
Wait-listed 920 (61.3) 549 (36.6) 32 (2.1)
Direct admission 694 (46.9) 673 (45.5) 112 (7.6)
1996–1997 <0.001
Wait-listed 929 (58.2) 625 (39.2) 41 (2.6)
Direct admission 761 (46.9) 776 (47.9) 84 (5.2)
1998–1999 <0.001
Wait-listed 829 (52.9) 675 (43.1) 62 (4.0)
Direct admission 867 (41.2) 984 (46.8) 251 (11.9)
2000–2001 <0.001
Wait-listed 525 (37.6) 724 (51.8) 148 (10.6)
Direct admission 413 (19.4) 1119 (52.6) 594 (27.9)
2002–2003 <0.001
Wait-listed 691 (40.6) 876 (51.4) 136 (8.0)
Direct admission 458 (23.6) 1037 (53.5) 444 (22.9)
2004–2005 <0.001
Wait-listed 489 (37.6) 692 (53.2) 119 (9.2)
Direct admission 461 (19.3) 1242 (52.1) 683 (28.6)
.
*Based on Northern New England Cardiovascular Disease Study Group [22].
†Compares the distribution of risk between wait-listed patients and direct admissions for each period.
length of the waiting-time interval required for a speci-
ﬁed proportion to undergo the operation. As measured by
the diﬀerence between 90th and 50th percentiles of the
wait time distributions, 40% of the 1998, 1999, 2004 and
2005 cohorts underwent surgery within 16 to 20 weeks
following the median waiting time (50th percentile), while
it took between 27 and 37 weeks for the cohorts in years
when supplementary funding was not available (Figure 2).
Periods 1992–1993 and 2004–2005 showed the short-
est waiting time and showed a notable diﬀerence in
changes of conditional remaining times between the peri-
ods (Figure 3). For each period, the remaining time during
which half of the patients were expected to access surgery
did not change for about the ﬁrst 10 weeks since decision.
After the ﬁrst 10 weeks, the conditional median times
for surgery remained relatively constant for period 2004–
2005, but these times increased with longer waits for
period 1992–1993. In contrast, in the two periods showing
the longest waiting times, namely 1996–1997 and 2002–
2003, the conditional median time decreased with the
longer waits, indicating perhaps an active wait-list man-
agement in years when the supplementary funding was
not provided.
Once wait-listed patients had a decision to operate, the
average weekly number of operations was lowest in 1996–
1997, 2000–2001, and 2002–2003 (Table 4). The average
rate of undergoing surgery from a wait list was about 5
procedures per 100 patient-weeks in these periods with
the lowest rates. After adjustment for patient-related fac-
tors, compared to the surgery rate in 1996–1997, the
weekly odds that a patient would undergo operation were
highest in 1992–1993, decreased to a low in 1996–1997,
rose in 1998–1999, decreased to another low in 2000–
2001 and 2002–2003, and then rose again in 2004–2005
(Table 4).
Access to surgery through direct admission
Among patients who had a decision to operate for CABG
and were directly admitted to hospital, times between
decision to operate and surgical revascularization were
longest in the periods 1992–1994, but were much shorter
than the times for wait-listed patients (Figure 4). During
these periods 80% of patients underwent surgery within 7
days. Half of patients underwent surgery within 1 day of
decision to operate and 80% within 5 days during periods
1995 and later.
Sobolev et al. BMC Health Services Research 2012, 12:311 Page 10 of 15
http://www.biomedcentral.com/1472-6963/12/311









































Figure 1 Estimated probability of surgical revascularization within a certain time of decision for surgical revascularization, by calendar
period of decision, among patients who accessed surgery through registration on a wait list.








































Figure 2 Time between decision to operate and surgical revascularization among patients who accessed surgery through registration on
a wait list, by calendar period of decision. Bottom of bar = 50th percentile, top of bar = 90th percentile.
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Figure 3 Conditional median time of surgical revascularization at a certain time since decision for surgical revascularization, by calendar
period of decision, among patients who accessed surgery through registration on a wait list.
Once direct admissions had a decision to operate, the
average daily number of operations was lowest in 1992–
1993 at about 23 procedures per 100 patient-days, rose
to about 36 procedures per 100 patient-days in 1998–
1999, after which the rate remained stable (Table 5). After
adjustment for patient-related factors, compared to the
Table 4 Average weekly rate of coronary artery bypass procedure in relation to calendar period of decision to proceed
with surgery, for patients registered on a wait list
Type of access by No. of No. of Total Crude rate† Crude OR‡ Adjusted OR ‡§‖
calendar period of decision patients procedures waiting time∗ (95% CI) (95% CI) (95% CI)
1992–1993 1726 1519 20462 7.4 (7.1–7.8) 1.7 (1.6–1.9) 2.0 (1.9–2.2)
1994–1995 1793 1545 26452 5.8 (5.5–6.1) 1.3 (1.2–1.4) 1.4 (1.3–1.5)
1996–1997 1862 1555 35054 4.4 (4.2–4.7) 1.0 1.0
1998–1999 1610 1426 21266 6.7 (6.4–7.1) 1.5 (1.4–1.6) 1.5 (1.4–1.7)
2000–2001 1791 1509 31887 4.7 (4.5–5.0) 1.1 (1.0–1.2) 1.1 (1.0–1.2)
2002–2003 1889 1613 35447 4.6 (4.3–4.8) 1.0 (0.9–1.1) 1.0 (0.9–1.1)
2004–2005 1359 1172 14252 8.2 (7.8–8.7) 1.9 (1.7–2.0) 1.9 (1.8–2.1)
All periods 12030 10339 184820 5.6 (5.5–5.7) – –
Abbreviations: OR = odds ratio; CI = conﬁdence interval.
*To measure waiting times, patients were followed for a maximum of 52 weeks.
†Per 100 patient weeks calculated as the number of procedures performed divided by the sum of waiting times.
‡As measured by odds ratios derived from discrete-time survival models, adjusting for consecutive weeks of waiting (0.5–52 weeks).
§Adjusted for sex, age at decision, urgency at decision, institution at decision, comorbidities at decision, coronary anatomy at decision, and time between
catheterization and decision.
‖218 patients with unknown values for urgency at decision were excluded.
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Figure 4 Time between decision to operate and surgical revascularization among patients who accessed surgery through direct
admission, by calendar period of decision. Bottom of bar = 50th percentile, top of bar = 80th percentile.
surgery rate in 1996–1997, the daily odds of surgery were
lower prior to 1996–1997, but higher after this period
(Table 5).
Time between catheterization and surgery
We found that for those who underwent CABG, times
between catheterization and surgical revascularization
were shorter among patients who accessed surgery
through direct admission compared to access through
wait-list registration. In the urgent group, half of direct
admissions underwent surgery within 1 week, whereas
half of wait-listed patients underwent surgery within 7
weeks. In addition, half of direct admissions and half
of wait-listed patients underwent surgery within 1 and
13 weeks respectively, in the semiurgent group. In the
nonurgent group these timeframes were 8 and 23 weeks,
respectively. The weekly odds of surgery after catheteriza-
tion were 4, 5, and 3 times higher among direct admissions
compared to wait-listed patients in the urgent, semiur-
gent, and nonurgent groups, respectively, after adjustment
for age, sex, hospital at catheterization, mode of admis-
sion at catheterization, comorbidity at surgery, hospital at
surgery, and coronary anatomy at surgery. We also found
that time between catheterization and decision to operate
became shorter in the 2000s compared to the 1990s for the
semiurgent group; the weekly rate of registration was 16%
and 25% higher in 2000–2001 and 2002–2003 compared
to 1996–1997. In the urgent group, these rates were 2.5
and 1.6 times higher in 2002–2003 and 2004–2005 com-
pared to 1996–1997. The weekly rates of decision were not
diﬀerent across calendar periods in the nonurgent group,
after adjustment.
Discussion
Coronary revascularization is indicated to alleviate chest
pain and to reduce the risk of death among patients who
have limiting angina that persists despite optimal medical
treatment and who have coronary anatomy that is suitable
for the procedure. However, in healthcare systems that
use wait lists to manage access to care, patients requir-
ing non-emergency surgical revascularization may have
to wait after the decision to operate. In this paper, we
sought to determine whether the year of decision to pro-
ceed with non-emergency CABG had an eﬀect on time
to surgery in a health system with publicly-funded uni-
versal coverage for the procedure. We estimated temporal
changes in the length of time that patients had to wait
between decision to operate and the procedure itself over
14 years that included several years with increases in fund-
ing.We focused on isolated CABG surgery because access
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Table 5 Average daily rate of coronary artery bypass procedure in relation to calendar period of decision to proceed with
surgery, for direct admissions
Type of access by No. of No. of Total Crude rate† Crude OR‡ Adjusted OR‡§‖
calendar period of decision patients procedures waiting time∗ (95% CI) (95% CI) (95% CI)
1992–1993 1204 1003 4228 23.7 (22.3–25.2) 0.7 (0.6–0.7) 0.7 (0.6–0.8)
1994–1995 1474 1270 4489 28.3 (26.7–29.8) 0.8 (0.7–0.9) 0.9 (0.8–0.9)
1996–1997 1621 1442 4173 34.6 (32.8–36.3) 1.0 1.0
1998–1999 2089 1920 5301 36.2 (34.6–37.8) 1.1 (1.0–1.2) 1.2 (1.1–1.3)
2000–2001 2121 1895 5579 34.0 (32.4–35.5) 1.0 (0.9–1.1) 1.2 (1.1–1.3)
2002–2003 1940 1740 5145 33.8 (32.2–35.4) 1.0 (0.9–1.1) 1.1 (1.0–1.2)
2004–2005 2369 2140 6206 34.5 (33.0–35.9) 1.0 (1.0–1.1) 1.2 (1.1–1.3)
All periods 12818 11410 35121 32.5 (31.9–33.1) – –
Abbreviations: OR = odds ratio; CI = conﬁdence interval.
*To measure waiting times, patients were followed for a maximum of 7 days.
†Per 100 patient days calculated as the number of procedures performed divided by the sum of waiting times.
‡As measured by odds ratios derived from discrete-time survival models, adjusting for consecutive days of waiting (0–7 days).
§Adjusted for sex, age at decision, urgency at decision, institution at decision, comorbidities at decision, coronary anatomy at decision, and time between
catheterization and decision.
‖1 patient with unknown value for sex was excluded.
to surgery could have been managed diﬀerently for com-
bined procedures than for isolated CABG. As a result, we
did not consider data from 312 (2%) wait-listed patients
and 211 (1%) directly-admitted patients whose procedure
was not isolated CABG.
We found that during two periods when supplemen-
tary funding was available, 1998–1999 and 2004–2005, the
weekly rate of undergoing surgery from a wait list was,
respectively, 50% and 90% higher than in 1996–1997, the
period with the longest waiting times. We also observed
a reduction in the diﬀerence in 90th and 50th percentiles
of the waiting-time distributions. Forty percent of patients
in the 1998, 1999, 2004 and 2005 cohorts (years when
supplementary funding was provided) underwent surgery
within 16 to 20 weeks following the median waiting time,
while it took between 27 and 37 weeks for the cohorts reg-
istered in the years when supplementary funding was not
available. Among patients who were directly admitted to
hospital, time between decision and surgery was longest
in 1992–1993 and then steadily decreased through the
late nineties. The rate of surgery among patients directly
admitted to hospital was the highest in 1998–1999, and
has not changed afterwards, even in years when supple-
mentary funding was provided.
The most important contribution of this analysis is
providing a more complete picture of access times for
the patient population requiring surgical revasculariza-
tion on a non-emergency basis in a health care system that
budgets the number of CABG procedures and uses sup-
plementary funding to reduce the number patients who
have to wait for the procedure and their waiting times. We
contrasted two pathways for accessing CABG. If angio-
plasty is not indicated when the cardiologist evaluates the
arterial lesions on the coronary angiogram, then a car-
diac surgeon is consulted to assess the patients’ suitability
for CABG. Patients are transferred to an in-patient ward
directly from the catheterization laboratory if expedited
assessment is necessary and, if deemed suitable, these
patients wait for the operation in hospital without regis-
tration on a wait list. Alternatively, a consultation with the
surgeon is scheduled at a later date. Surgeons register on
their wait lists patients who need CABG and for whom the
operation can be safely delayed. To address this issue, we
studied access to surgical coronary revascularization for
non-emergency patients through direct admission to hos-
pital at the surgeon’s discretion, and contrasted the total
amount of time between cardiac catheterization and sur-
gical revascularization for the two pathways: through a
wait list and through direct admission.
In this analysis, a potential concern is the misclassi-
ﬁcation of the recorded urgency for treatment, because
surgeons may manage access to surgery on the basis of
various considerations, such as the best use of operating
time or the availability of hospital resources. Therefore,
the outcome might have been inﬂuenced by the individual
surgeon’s threshold for accepting a patient for nonurgent
treatment. It is plausible that the time to surgery may
diﬀer between patients treated by surgeons with a high
volume of CABG procedures and surgeons who perform
a diverse range of cardiac procedures.
We did not have access to detailed information about
physicians’ decision-making on access to the procedure.
To explore further the eﬀect of the supplementary fund-
ing, we classiﬁed all patients using the algorithm devel-
oped by Northern New England Cardiovascular Disease
Study Group [22]. The percentage of low risk patients
Sobolev et al. BMC Health Services Research 2012, 12:311 Page 14 of 15
http://www.biomedcentral.com/1472-6963/12/311
accessing surgery through direct admission declined con-
siderably in years when supplementary funding was pro-
vided.
More research is needed to evaluate whether waiting
times for non-emergency surgery vary because of chance
alone after adjustment for clinical factors and variation in
supply. For example, it remains unclear whether directly
admitting patients of low risk is done to circumvent long
wait lists, or to substitute for cancellations on the operat-
ing room schedule.
Since 2002, percutaneous coronary intervention has
become an increasingly common method of coronary
revascularization, leading to a considerable change in the
composition of patient population for both catheter-based
and surgical procedures. We only had data for the period
before 2005, and therefore our analysis could not adjust
for changes in the proportional use of surgical revascular-
ization over the past decade.
Conclusions
Our study provides evidence that waiting times for non-
emergency coronary bypass surgery shortened after sup-
plementary funding was granted to increase volume of
cardiac surgical care in a health system with publicly-
funded universal coverage for the procedure. The eﬀect of
the supplementary funding was not uniform for patients
that access the services through wait lists and through
direct admissions. This might indicate that surgical ser-
vices have used supplementary funding and direct admis-
sions as two independent mechanisms to provide more
treatments without delay. Considering that the hospitals
had capacity to increase the number of operations, the
supply-side initiatives indeed were eﬀective in reducing
waiting times. Perhaps it was an empirical way to ﬁnd
the level to budget the number of surgeries in the well
deﬁned population. In our view, some further options for
improving access to cardiac care should include policies
for eﬀective management of patient ﬂow.
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